FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1499455897> ?p ?o ?g. }

• W1499455897 endingPage "432" @default.
• W1499455897 startingPage "425" @default.
• W1499455897 abstract "BACKGROUND The effective management of fatigue in patients with cancer requires a clear delineation of what constitutes nontrivial fatigue. The authors defined numeric cutpoints for fatigue severity based on functional interference and described the prevalence and characteristics of fatigue in patients with cancer and survivors. METHODS In a multicenter study, outpatients with breast, prostate, colorectal, or lung cancer rated their fatigue severity and symptom interference with functioning on the M. D. Anderson Symptom Inventory numeric scale of 0 to 10. Ratings of symptom interference guided the selection of numeric rating cutpoints between mild, moderate, and severe fatigue levels. Regression analysis identified significant factors related to reporting moderate/severe fatigue. RESULTS The statistically optimal cutpoints were ≥ 4 for moderate fatigue and ≥ 7 for severe fatigue. Moderate/severe fatigue was reported by 983 of 2177 patients (45%) undergoing active treatment and was more likely to occur in patients receiving treatment with strong opioids (odds ratio [OR], 3.00), those with a poor Eastern Cooperative Oncology Group performance status (OR, 2.00), those who had > 5% weight loss within 6 months (OR, 1.60), those who were receiving > 10 medications (OR, 1.58), those with lung cancer (OR, 1.55), and those with a history of depression (OR, 1.42). Among survivors (patients with complete remission or no evidence of disease, and not currently receiving cancer treatment), 29% of patients (150 of 515 patients) had moderate/severe fatigue that was associated with poor performance status (OR, 3.48) and a history of depression (OR, 2.21). CONCLUSIONS The current study statistically defined fatigue severity categories related to significantly increased symptom interference. The high prevalence of moderate/severe fatigue in both actively treated patients with cancer and survivors warrants the promoting of the routine assessment and management of patient‐reported fatigue. Cancer 2014;120:425–432 . © 2013 American Cancer Society ." @default.
• W1499455897 created "2016-06-24" @default.
• W1499455897 creator A5021287787 @default.
• W1499455897 creator A5031788907 @default.
• W1499455897 creator A5032101004 @default.
• W1499455897 creator A5033903352 @default.
• W1499455897 creator A5038425269 @default.
• W1499455897 creator A5039180386 @default.
• W1499455897 creator A5090643981 @default.
• W1499455897 date "2013-11-05" @default.
• W1499455897 modified "2023-10-14" @default.
• W1499455897 title "Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors" @default.
• W1499455897 cites W1509242347 @default.
• W1499455897 cites W1940235639 @default.
• W1499455897 cites W2001038217 @default.
• W1499455897 cites W2001638015 @default.
• W1499455897 cites W2007848580 @default.
• W1499455897 cites W2026548146 @default.
• W1499455897 cites W2031850236 @default.
• W1499455897 cites W2036071389 @default.
• W1499455897 cites W2038962823 @default.
• W1499455897 cites W2050104081 @default.
• W1499455897 cites W2053616913 @default.
• W1499455897 cites W2054118100 @default.
• W1499455897 cites W2057673891 @default.
• W1499455897 cites W2090628055 @default.
• W1499455897 cites W2109364152 @default.
• W1499455897 cites W2109659496 @default.
• W1499455897 cites W2119968490 @default.
• W1499455897 cites W2128593424 @default.
• W1499455897 cites W2147603975 @default.
• W1499455897 cites W2162333871 @default.
• W1499455897 cites W2163154181 @default.
• W1499455897 cites W2163814384 @default.
• W1499455897 doi "https://doi.org/10.1002/cncr.28434" @default.
• W1499455897 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3949157" @default.
• W1499455897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24436136" @default.
• W1499455897 hasPublicationYear "2013" @default.
• W1499455897 type Work @default.
• W1499455897 sameAs 1499455897 @default.
• W1499455897 citedByCount "241" @default.
• W1499455897 countsByYear W14994558972014 @default.
• W1499455897 countsByYear W14994558972015 @default.
• W1499455897 countsByYear W14994558972016 @default.
• W1499455897 countsByYear W14994558972017 @default.
• W1499455897 countsByYear W14994558972018 @default.
• W1499455897 countsByYear W14994558972019 @default.
• W1499455897 countsByYear W14994558972020 @default.
• W1499455897 countsByYear W14994558972021 @default.
• W1499455897 countsByYear W14994558972022 @default.
• W1499455897 countsByYear W14994558972023 @default.
• W1499455897 crossrefType "journal-article" @default.
• W1499455897 hasAuthorship W1499455897A5021287787 @default.
• W1499455897 hasAuthorship W1499455897A5031788907 @default.
• W1499455897 hasAuthorship W1499455897A5032101004 @default.
• W1499455897 hasAuthorship W1499455897A5033903352 @default.
• W1499455897 hasAuthorship W1499455897A5038425269 @default.
• W1499455897 hasAuthorship W1499455897A5039180386 @default.
• W1499455897 hasAuthorship W1499455897A5090643981 @default.
• W1499455897 hasBestOaLocation W14994558972 @default.
• W1499455897 hasConcept C121608353 @default.
• W1499455897 hasConcept C126322002 @default.
• W1499455897 hasConcept C139719470 @default.
• W1499455897 hasConcept C156957248 @default.
• W1499455897 hasConcept C162324750 @default.
• W1499455897 hasConcept C1862650 @default.
• W1499455897 hasConcept C2776256026 @default.
• W1499455897 hasConcept C2776867660 @default.
• W1499455897 hasConcept C2778141389 @default.
• W1499455897 hasConcept C526805850 @default.
• W1499455897 hasConcept C530470458 @default.
• W1499455897 hasConcept C71924100 @default.
• W1499455897 hasConceptScore W1499455897C121608353 @default.
• W1499455897 hasConceptScore W1499455897C126322002 @default.
• W1499455897 hasConceptScore W1499455897C139719470 @default.
• W1499455897 hasConceptScore W1499455897C156957248 @default.
• W1499455897 hasConceptScore W1499455897C162324750 @default.
• W1499455897 hasConceptScore W1499455897C1862650 @default.
• W1499455897 hasConceptScore W1499455897C2776256026 @default.
• W1499455897 hasConceptScore W1499455897C2776867660 @default.
• W1499455897 hasConceptScore W1499455897C2778141389 @default.
• W1499455897 hasConceptScore W1499455897C526805850 @default.
• W1499455897 hasConceptScore W1499455897C530470458 @default.
• W1499455897 hasConceptScore W1499455897C71924100 @default.
• W1499455897 hasFunder F4320332161 @default.
• W1499455897 hasFunder F4320337351 @default.
• W1499455897 hasIssue "3" @default.
• W1499455897 hasLocation W14994558971 @default.
• W1499455897 hasLocation W14994558972 @default.
• W1499455897 hasLocation W14994558973 @default.
• W1499455897 hasLocation W14994558974 @default.
• W1499455897 hasOpenAccess W1499455897 @default.
• W1499455897 hasPrimaryLocation W14994558971 @default.
• W1499455897 hasRelatedWork W2064573700 @default.
• W1499455897 hasRelatedWork W2121111473 @default.
• W1499455897 hasRelatedWork W2172237894 @default.
• W1499455897 hasRelatedWork W2370262613 @default.
• W1499455897 hasRelatedWork W2374019147 @default.

• next